Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24244200)
Watch
English
Single agent versus combination chemotherapy for metastatic breast cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
meta-analysis
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Single agent versus combination chemotherapy for metastatic breast cancer
(English)
0 references
main subject
metastatic breast cancer
1 reference
based on heuristic
inferred from title
chemotherapy
0 references
author
Nicholas Wilcken
series ordinal
6
0 references
Davina Ghersi
series ordinal
4
0 references
author name string
Sue Carrick
series ordinal
1
0 references
Sharon Parker
series ordinal
2
0 references
Charlene E Thornton
series ordinal
3
0 references
John Simes
series ordinal
5
0 references
publication date
20 April 2005
0 references
published in
Cochrane Database of Systematic Reviews
0 references
cites work
A daily diary for quality of life measurement in advanced breast cancer trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
21 January 2018
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
21 January 2018
Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
21 January 2018
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparative study of PALA, PALA plus 5-FU, and 5-FU in advanced breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weekly adriamycin versus VAC in advanced breast cancer. A randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beta blockade during and after myocardial infarction: an overview of the randomized trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Refractory breast cancer: a comparison of two different chemotherapy regimens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD003372.PUB2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/14651858.CD003372.PUB2
0 references
PubMed publication ID
15846660
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
